BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 30015227)

  • 21. Thromboprophylaxis patterns, risk factors, and outcomes of care in the medically ill patient population.
    Mahan CE; Fisher MD; Mills RM; Fields LE; Stephenson JJ; Fu AC; Spyropoulos AC
    Thromb Res; 2013 Nov; 132(5):520-6. PubMed ID: 24080150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors for venous thromboembolism after acute trauma: A population-based case-cohort study.
    Park MS; Perkins SE; Spears GM; Ashrani AA; Leibson CL; Boos CM; Harmsen WS; Jenkins DH; Bailey KR; Ballman KV; Heit JA
    Thromb Res; 2016 Aug; 144():40-5. PubMed ID: 27284980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prescribing patterns and outcomes of venous thromboembolism prophylaxis in hospitalized medical and cancer patients: Observations from the Ottawa Hospital.
    Budd AC; Rhodes M; Forster AJ; Noghani P; Carrier M; Wells PS
    Thromb Res; 2021 Jan; 197():144-152. PubMed ID: 33217622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The MARINER trial of rivaroxaban after hospital discharge for medical patients at high risk of VTE. Design, rationale, and clinical implications.
    Raskob GE; Spyropoulos AC; Zrubek J; Ageno W; Albers G; Elliott CG; Halperin J; Haskell L; Hiatt WR; Maynard GA; Peters G; Spiro T; Steg PG; Suh EY; Weitz JI
    Thromb Haemost; 2016 Jun; 115(6):1240-8. PubMed ID: 26842902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risks and cost burden of venous thromboembolism and bleeding for patients undergoing total hip or knee replacement in a managed-care population.
    Vekeman F; LaMori JC; Laliberté F; Nutescu E; Duh MS; Bookhart BK; Schein J; Dea K; Olson WH; Lefebvre P
    J Med Econ; 2011; 14(3):324-34. PubMed ID: 21506632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk Factors for Major Bleeding During Anticoagulation Therapy in Cancer-Associated Venous Thromboembolism - From the COMMAND VTE Registry.
    Nishimoto Y; Yamashita Y; Kim K; Morimoto T; Saga S; Amano H; Takase T; Hiramori S; Oi M; Akao M; Kobayashi Y; Toyofuku M; Izumi T; Tada T; Chen PM; Murata K; Tsuyuki Y; Sasa T; Sakamoto J; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Yoshikawa Y; Shiomi H; Kato T; Makiyama T; Ono K; Sato Y; Kimura T;
    Circ J; 2020 Oct; 84(11):2006-2014. PubMed ID: 33012736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of falls and bleeding in elderly patients with acute venous thromboembolism.
    Kämpfen P; Méan M; Limacher A; Righini M; Jaeger K; Beer HJ; Osterwalder J; Frauchiger B; Matter CM; Kucher N; Cornuz J; Banyai M; Egloff M; Aschwanden M; Bounameaux H; Rodondi N; Aujesky D
    J Intern Med; 2014 Oct; 276(4):378-86. PubMed ID: 24645727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of Venous Thromboembolism in Hospitalized Medically Ill Patients: A U.S. Perspective.
    Spyropoulos AC; Ageno W; Cohen AT; Gibson CM; Goldhaber SZ; Raskob G
    Thromb Haemost; 2020 Jun; 120(6):924-936. PubMed ID: 32492724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New paradigms in venous thromboprophylaxis of medically ill patients.
    Spyropoulos AC; Raskob GE
    Thromb Haemost; 2017 Aug; 117(9):1662-1670. PubMed ID: 28640324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention and Treatment of Venous Thromboembolism in Patients with Cancer: Focus on Drug Therapy.
    van Es N; Bleker SM; Wilts IT; Porreca E; Di Nisio M
    Drugs; 2016 Mar; 76(3):331-41. PubMed ID: 26729187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retrospective evaluation of venous thromboembolism prophylaxis in the adult cancer population.
    Reeves D; Liu CY
    J Oncol Pharm Pract; 2010 Mar; 16(1):27-31. PubMed ID: 19401307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cohort Study on the Management of Cancer-Associated Venous Thromboembolism Aimed at the Safety of Stopping Anticoagulant Therapy in Patients Cured of Cancer.
    van der Hulle T; den Exter PL; van den Hoven P; van der Hoeven JJ; van der Meer FJ; Eikenboom J; Huisman MV; Klok FA
    Chest; 2016 May; 149(5):1245-51. PubMed ID: 26836911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Frequency of venous thromboembolism among hospitalized patients with cancer].
    Conte G; Figueroa G
    Rev Med Chil; 2008 Dec; 136(12):1528-34. PubMed ID: 19350169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benefit-Risk Assessment of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness.
    Raskob GE; Ageno W; Albers G; Elliott CG; Halperin J; Maynard G; Steg PG; Weitz JI; Albanese J; Yuan Z; Levitan B; Lu W; Suh EY; Spiro T; Lipardi C; Barnathan ES; Spyropoulos AC
    J Am Heart Assoc; 2022 Oct; 11(20):e026229. PubMed ID: 36205248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk stratification and venous thromboprophylaxis in hospitalized medical and cancer patients.
    Prandoni P; Samama MM
    Br J Haematol; 2008 May; 141(5):587-97. PubMed ID: 18422787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: a randomized trial.
    Hull RD; Schellong SM; Tapson VF; Monreal M; Samama MM; Nicol P; Vicaut E; Turpie AG; Yusen RD;
    Ann Intern Med; 2010 Jul; 153(1):8-18. PubMed ID: 20621900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identifying predictors for bleeding in hospitalized cancer patients: A cohort study.
    Patell R; Gutierrez A; Rybicki L; Khorana AA
    Thromb Res; 2017 Oct; 158():38-43. PubMed ID: 28820967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment with dabigatran or warfarin in patients with venous thromboembolism and cancer.
    Schulman S; Goldhaber SZ; Kearon C; Kakkar AK; Schellong S; Eriksson H; Hantel S; Feuring M; Kreuzer J
    Thromb Haemost; 2015 Jul; 114(1):150-7. PubMed ID: 25739680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hospital-related first venous thromboembolism and risk of recurrence.
    Bjøri E; Arshad N; Johnsen HS; Hansen JB; Braekkan SK
    J Thromb Haemost; 2016 Dec; 14(12):2368-2375. PubMed ID: 27589573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada.
    Kahn SR; Panju A; Geerts W; Pineo GF; Desjardins L; Turpie AG; Glezer S; Thabane L; Sebaldt RJ;
    Thromb Res; 2007; 119(2):145-55. PubMed ID: 16516275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.